388 related articles for article (PubMed ID: 12361817)
1. Novel insulins: expanding options in diabetes management.
Gerich JE
Am J Med; 2002 Sep; 113(4):308-16. PubMed ID: 12361817
[TBL] [Abstract][Full Text] [Related]
2. Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.
Mayfield JA; White RD
Am Fam Physician; 2004 Aug; 70(3):489-500. PubMed ID: 15317436
[TBL] [Abstract][Full Text] [Related]
3. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
[TBL] [Abstract][Full Text] [Related]
5. [An update on multiple insulin injection therapy in type 1 and 2 diabetes].
Varanauskiene E; Varanauskaite I; Ceponis J
Medicina (Kaunas); 2006; 42(9):770-9. PubMed ID: 17028476
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
Roach P; Woodworth JR
Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
[TBL] [Abstract][Full Text] [Related]
7. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
8. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
[TBL] [Abstract][Full Text] [Related]
9. Inhaled insulin: Exubera.
Odegard PS; Capoccia KL
Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
[TBL] [Abstract][Full Text] [Related]
10. Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
McKeage K; Goa KL
Treat Endocrinol; 2002; 1(1):55-8. PubMed ID: 15765621
[TBL] [Abstract][Full Text] [Related]
11. Insulin analogues: new dimension of management of diabetes mellitus.
Siddiqui NI
Mymensingh Med J; 2007 Jan; 16(1):117-21. PubMed ID: 17344794
[TBL] [Abstract][Full Text] [Related]
12. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
[TBL] [Abstract][Full Text] [Related]
13. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
Burge MR; Waters DL; Holcombe JH; Schade DS
J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
[TBL] [Abstract][Full Text] [Related]
14. Spotlight on insulin aspart in type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Treat Endocrinol; 2003; 2(1):71-6. PubMed ID: 15871555
[TBL] [Abstract][Full Text] [Related]
15. Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects?
Valensi P; Cosson E
Diabetes Metab; 2005 Sep; 31(4 Pt 2):4S34-4S39. PubMed ID: 16389896
[TBL] [Abstract][Full Text] [Related]
16. Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.
Reynolds NA; Wagstaff AJ
Drugs; 2004; 64(17):1957-74. PubMed ID: 15329046
[TBL] [Abstract][Full Text] [Related]
17. Insulin glargine.
Campbell RK; White JR; Levien T; Baker D
Clin Ther; 2001 Dec; 23(12):1938-57; discussion 1923. PubMed ID: 11813930
[TBL] [Abstract][Full Text] [Related]
18. Insulin glargine: an updated review of its use in the management of diabetes mellitus.
Dunn CJ; Plosker GL; Keating GM; McKeage K; Scott LJ
Drugs; 2003; 63(16):1743-78. PubMed ID: 12904090
[TBL] [Abstract][Full Text] [Related]
19. Insulin glargine: a new basal insulin.
Levien TL; Baker DE; White JR; Campbell RK
Ann Pharmacother; 2002 Jun; 36(6):1019-27. PubMed ID: 12022906
[TBL] [Abstract][Full Text] [Related]
20. Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus.
Chatterjee S; Tringham JR; Davies MJ
Expert Opin Pharmacother; 2006 Jul; 7(10):1357-71. PubMed ID: 16805721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
